col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


38 Ergebisse       Seite 1

 [1] 
EMBO: EMBO Reports
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jul―26 Mucosal IFNλ1 mRNA-based immunomodulation effectively reduces SARS-CoV-2 induced mortality in mice Anna Macht, Yiqi Huang, Line S Reinert, Vincent Grass, Kristin Lohmer, Elke Tatjana Aristizabal Prada, et al. (+12)
2 [GO] 2024―Jul―15 Novel immunomodulatory properties of adenosine analogs promote their antiviral activity against SARS-CoV-2 Giulia Monticone, Zhi Huang, Peter Hewins, Thomasina Cook, Oygul Mirzalieva, Brionna King, et al. (+18)
3 [GO] 2024―Mai―30 Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication Pasqualino de Antonellis, Veronica Ferrucci, Marco Miceli, Francesca Bibbo, Fatemeh Asadzadeh, Francesca Gorini, et al. (+20)
4 [GO] 2024―Jan―02 The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactions Dimitriya H Garvanska, R Elias Alvarado, Filip Oskar Mundt, Richard Lindqvist, Josephine Kerzel Duel, Fabian Coscia, et al. (+18)
5 [GO] 2023―Nov―02 Antibody-mediated SARS-CoV-2 entry in cultured cells Md Golam Kibria, Christy L Lavine, Weichun Tang, Shaowei Wang, Hailong Gao, Wei Shi, et al. (+11)
6 [GO] 2023―Okt―23 ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS Martin Müller, Alexandra Herrmann, Shigeru Fujita, Keiya Uriu, Carolin Kruth, Adam Strange, et al. (+8)
7 [GO] 2023―Okt―12 Immune-epithelial cell cross-talk enhances antiviral responsiveness to SARS-CoV-2 in children Vladimir G Magalhães, Sören Lukassen, Maike Drechsler, Jennifer Loske, Sandy S Burkart, Sandra Wüst, et al. (+9)
8 [GO] 2023―Okt―12 Tetherin antagonism by SARS-CoV-2 ORF3a and spike protein enhances virus release Hazel Stewart, Roberta Palmulli, Kristoffer H Johansen, Naomi McGovern, Ola M Shehata, George W Carnell, et al. (+9)
9 [GO] 2023―Mai―15 Antiviral activity of the human endogenous retrovirus-R envelope protein against SARS-CoV-2 Shabnam Ansari, Nidhi Gupta, Rohit Verma, Oinam N Singh, Jyoti Gupta, Amit Kumar, et al. (+11)
10 [GO] 2023―Mrz―23 Scalable RT-LAMP-based SARS-CoV-2 testing for infection surveillance with applications in pandemic preparedness Dan Lou, Matthias Meurer, Svetlana Ovchinnikova, Robin Burk, Anna Denzler, Konrad Herbst, et al. (+23)
11 [GO] 2023―Mrz―07 Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice Adam D Kenney, Ashley Zani, Jeffrey Kawahara, Adrian C Eddy, Xiao-Liang Wang, KC Mahesh, et al. (+12)
12 [GO] 2023―Mrz―06 SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19 Sarah Temmam, Xavier Montagutelli, Cécile Herate, Flora Donati, Béatrice Regnault, Mikael Attia, et al. (+19)
13 [GO] 2023―Mrz―06 Vitamin C promotes ACE2 degradation and protects against SARS-CoV-2 infection Yibo Zuo, Zhijin Zheng, Yingkang Huang, Jiuyi He, Lichao Zang, Tengfei Ren, et al. (+9)
14 [GO] 2023―Mrz―06 Low hanging fruit for combatting SARS-CoV-2? Diego Cantoni, Joe Grove
15 [GO] 2022―Okt―26 Nsp16 shields SARS-CoV -2 from efficient MDA5 sensing and IFIT1 -mediated restriction Alina Russ, Sabine Wittmann, Yuta Tsukamoto, Alexandra Herrmann, Janina Deutschmann, Justine Lagisquet, et al. (+3)
16 [GO] 2022―Aug―24 Evolutionary remodelling of N-terminal domain loops fine-tunes SARS-CoV -2 spike Diego Cantoni, Matthew J. Murray, Mphatso D. Kalemera, Samuel J. Dicken, Lenka Stejskal, Georgina Brown, et al. (+24)
17 [GO] 2022―Aug―16 Impaired activation of transposable elements in SARS-CoV -2 infection Matan Sorek, Eran Meshorer, Sharon Schlesinger
18 [GO] 2022―Jul―28 After 2 years of a pandemic, students are struggling to find strong reference letters David R Smith
19 [GO] 2022―Mai―12 Potent neutralization by monoclonal human IgM against SARS-CoV-2 is impaired by class switch Ilaria Callegari, Mika Schneider, Giuliano Berloffa, Tobias Mühlethaler, Sebastian Holdermann, Edoardo Galli, et al. (+9)
20 [GO] 2022―Mai―09 ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion Georg Jocher, Vincent Grass, Sarah K Tschirner, Lydia Riepler, Stephan Breimann, Tuğberk Kaya, et al. (+11)
21 [GO] 2022―Apr―25 A human coronavirus OC43-derived polypeptide causes neuropathic pain Veronica I Shubayev, Jennifer Dolkas, Glaucilene Ferreira Catroli, Andrei V Chernov
22 [GO] 2022―Mrz―07 Biparatopic sybodies neutralize SARS-CoV-2 variants of concern and mitigate drug resistance Justin D Walter, Melanie Scherer, Cedric A J Hutter, Alisa A Garaeva, Iwan Zimmermann, Marianne Wyss, et al. (+17)
23 [GO] 2022―Mrz―03 A simple reverse genetics method to generate recombinant coronaviruses Julien Mélade, Géraldine Piorkowski, Franck Touret, Toscane Fourié, Jean-Sélim Driouich, Maxime Cochin, et al. (+4)
24 [GO] 2022―Feb―23 Lamarck redux and other false arguments against SARS-CoV-2 vaccination Emanuel Goldman
25 [GO] 2021―Dez―20 Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern Teresa R Wagner, Daniel Schnepf, Julius Beer, Natalia Ruetalo, Karin Klingel, Philipp D Kaiser, et al. (+10)
26 [GO] 2021―Dez―16 A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection Meetali Singh, Maxime Chazal, Piergiuseppe Quarato, Loan Bourdon, Christophe Malabat, Thomas Vallet, et al. (+9)
27 [GO] 2021―Dez―02 DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging Sara Sepe, Francesca Rossiello, Valeria Cancila, Fabio Iannelli, Valentina Matti, Giada Cicio, et al. (+8)
28 [GO] 2021―Sep―17 Lessons from COVID-19 Philip Hunter
29 [GO] 2021―Sep―07 How many animals are used for SARS-CoV-2 research? Philipp Schwedhelm, Johanna Kusnick, Céline Heinl, Gilbert Schönfelder, Bettina Bert
30 [GO] 2021―Sep―03 COVID-19 and the gain of function debates Kelsey Lane Warmbrod, Michael G Montague, Gigi Kwik Gronvall
31 [GO] 2021―Mai―25 The COVID-19 pandemic: agile versus blundering communication during a worldwide crisis Gaby-Fleur Böl
32 [GO] 2021―Apr―28 Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-chip model Vivek V Thacker, Kunal Sharma, Neeraj Dhar, Gian-Filippo Mancini, Jessica Sordet-Dessimoz, John D McKinney
33 [GO] 2021―Apr―27 NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodies Teresa R Wagner, Elena Ostertag, Philipp D Kaiser, Marius Gramlich, Natalia Ruetalo, Daniel Junker, et al. (+17)
34 [GO] 2021―Mrz―24 COVID-19 and the opportunities for research Philip Hunter
35 [GO] 2021―Feb―22 A CRISPR response to pandemics? Federico Germani, Sebastian Wäscher, Nikola Biller-Andorno
36 [GO] 2020―Okt―28 SARS-CoV-2 evades immune detection in alveolar macrophages Louise Dalskov, Michelle Møhlenberg, Jacob Thyrsted, Julia Blay-Cadanet, Ebbe Toftgaard Poulsen, Birgitte Holst Folkersen, et al. (+7)
37 [GO] 2020―Aug―12 Data protection during the coronavirus crisis Christophe Olivier Schneble, Bernice Simone Elger, David Martin Shaw
38 [GO] 2020―Mrz―17 The spread of the COVID -19 coronavirus Philip Hunter
 [1] 

38 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec